Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.

Each year Region Skåne in Sweden gathers information on drug prescriptions within the region. The last ten years a significant pattern of uneven prescription rates of ADHD drugs to people up to 17 years of age are noticed in the different districts. These regional differences are noticed in other regions in Sweden as well and internationally.

The convention on the rights of the child became an institutional law in Sweden in 2020 and it emphasises that each child has the right to equal care and treatment. Therefore it is of importance to analyse how the variations in prescriptions rates arise and if we as healthcare providers can influence it. Our study is a collaboration between Region Skåne and the university of Lund and is a part of a larger study of the regional variations of prescriptions of ADHD drugs. Previous research informs us that a complex interplay of multiple factors can be behind variations in prescription rates among medical doctors and not the least subjective experiences and attitudes.

Our study performs semistructured interviews of Region Skånes child and adolescent psychiatrists with questions specifically regarding their own experiences and attitudes that might influence their prescription behavior.

The intention is to gather information that can guide future research questions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Attitude ADHD - Combined Type Behavior Physician's Role

Sex eligibility

All sexes

Study type

Observational

Primary location

Child and Adolescent Psychiatry, Region Skane

Malmö, 20502, Sweden

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

child and adolescent psychiatrist in Region Skåne

Exclusion criteria

part of the research group

Treatment and study plan

Semi structured interview

Other

Interviews are performed by one research group member and based on beforehand decided questions and sub-questions. The interview material is transcribed and analysed on a theme level.

Primary outcomes

Attitudes and experiences associated with prescription and diagnosis of ADHD

Time frame: 1 day (During the analysis of the transcribed interview)

Semistructured interview

Sponsors and collaborators

Lead sponsor

Lund University

Other

Collaborators

Region Skane

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Mar 16, 2021
Registry last updated: Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed